Gen-Probe to Spin Off Industrial Testing Assets | GenomeWeb

NEW YORK (GenomeWeb News) – Gen-Probe is spinning off its industrial testing assets into a new, independently operated company that will develop molecular assays for biopharmaceutical production, water and food safety testing, and other applications, the firm said today.

The new company will be called Roka Bioscience, and Gen-Probe will hold a 19.9 percent stake in the firm. It will begin operations as an independent entity immediately, with 18 Gen-Probe employees joining Roka.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.